This Week in Cell

Researchers at the BC Cancer Agency, University of British Columbia, and elsewhere explore interactions between malignant and immune cells in dozens of individuals with high-grade serous ovarian cancer, using multi-region sampling and a combination of genome sequencing, immunohistochemistry, expression profiling, immune cell receptor sequencing, and other approaches.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.